3//SEC Filing
Flagship Pioneering Fund VII, L.P. 3
Accession 0000899243-22-020532
CIK 0001694665other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 7:00 PM ET
Size
7.1 KB
Accession
0000899243-22-020532
Insider Transaction Report
Form 3
Holdings
- 13,698,630(indirect: By Flagship Pioneering Fund VII, L.P.)
Common Stock
Footnotes (2)
- [F1]On May 27, 2022, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 13,698,630 shares of the Issuer's Common Stock in registered direct offering at a price of $1.46 per share.
- [F2]Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the Chief Executive Officer, director and sole stockholder of Flagship Pioneering. Each of Flagship Fund VII GP, Flagship Pioneering and Dr. Afeyan disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001805916
Filing Metadata
- Form type
- 3
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 7:00 PM ET
- Size
- 7.1 KB